Loading clinical trials...
Loading clinical trials...
Prophylactic Amnioinfusion for Prevention of Postpartum Hemorrhage: A Randomized Clinical Trial (PURPOSE)
The purpose of this study is to decrease the likelihood of composite postpartum hemorrhage (PPH) morbidity, which consists of i) Estimated or quantified blood loss of 1,500 mL or more, ii) transfusion of any blood products or iii) hysterectomy
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Start Date
November 11, 2024
Primary Completion Date
November 11, 2026
Completion Date
May 1, 2027
Last Updated
November 18, 2024
700
ESTIMATED participants
Saline delivered using an intrauterine pressure catheter (IUPC)
COMBINATION_PRODUCT
Lead Sponsor
The University of Texas Health Science Center, Houston
NCT07034924
NCT05290129
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05245227